GET THE APP

..

Pulmonary & Respiratory Medicine

ISSN: 2161-105X

Open Access

A Perspective on the Majority of Current Coronavirus Medications is either orally or intravenously

Abstract

Sunena Williams*

A small amount of the drug is delivered to the lung because to poor absorption or gastrointestinal degradation in the vast majority of ongoing antiviral/hostile to SARS-CoV-2 specialists that are taken orally. In order to treat pneumonic diseases like the Coronavirus, breathed-in treatment by pneumonic medicine conveyance could be considered an expected strategy. It is possible to directly deliver pharmaceuticals to the lung using pneumonic conveyance, which ensures higher medication fixation in the lung and avoids unpleasant side effects because lesser dosages are needed.

HTML PDF

Share this article

Google Scholar citation report
Citations: 1690

Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward